Your browser does not support JavaScript!

 

 

[2021-10-07] Can Patients with Parkinson's Disease Improve their Life Quality? Experts Show you the Key Password of Nutrition
Parkinson's disease is a degenerative disease of the brain. When the substantia nigra cells in the brain degenerate and die in large numbers with only 20% left, the amount of dopamine secreted is not enough to support motor nerve conduction. It results in abnormal motor function symptoms such as involuntary trembling, muscle stiffness, slow movement, and loss of balance. The onset age is about 50 to 60 years old. At present, there is no effective way to do repair treatment, but scientific research has proved that through injecting G-CSF to drive autologous CD34 stem cells might help improve the life quality of patients with Parkinson's disease.

Professor Jia-Jing Ling of NIU has been involved in animal research for many years paying long-term attention to anti-aging and stem research. Seventeen years ago, her mother began to have involuntary tremors in her arms and legs and was diagnosed with Parkinson's disease. She was not willing to see her mother suffer from her illness and hoped to prolong her life. From her professional perspective, Professor Jia-Jing Ling hoped to find a solution to slow down her mother's deterioration and pain. Professor Lin began to study the combination of G-CSF with SCF and microcrystalline sphere encapsulation technology, hoping to use it as a daily nutritional supplement for her mother. After years of research, Professor Lin has finally developed this patented technology.


CD34 is a special protein on the surface of blood stem cell membrane. It belongs to bone marrow stem cell growth factor. It is the most important message to stimulate bone marrow to produce autologous stem cells. It has the ability of self-replication and differentiation into other functional cells. Dr. Chang-Ping Chen, who has been committed to health research for many years, said that according to the clinical research of regenerative medicine at home and abroad, activated CD34 hematopoietic stem cells can repair body functions. Therefore, if patients with Parkinson's disease are given enhanced CD34 hematopoietic stem cells, there is a chance for the brain black cells being activated. At present, the clinical application of CD34 hematopoietic stem cells includes anti-aging treatment and treatment of brain diseases, cancer chemotherapy, treatments of diabetes as well as cardiovascular disease.

After years of animal experiments, Professor Jia-Jing Lin's research team confirmed that the active protein coated with microcrystalline spheres can avoid being digested by gastric acid when people taking it, and can also be absorbed and utilized by the human body. It can be sent to the bone marrow to produce stem cells, and then repair the damaged brain area of the brain of guinea pig with Parkinson's disease.

Recently, Professor Jia-Jing Lin and Dr. Chang-Ping Chen jointly published a new book titled "Stem Cell Nutrition", calling on the public to use correct concepts and living habits to activate the key autologous stem cells, to increase immunity and repair power, and to reduce the risk of causing chronic diseases.
瀏覽數  
將此文章推薦給親友
請輸入此驗證碼
Voice Play
更換驗證碼